Reviewed profile

food and beverage brand · public preview

Jardiance

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Headquarters
Germany
Is this your company?Claim Jardiance to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Jardiance — no cold outreach.
Report a changeLog in for full recordLast reviewed 11 Jun 2026 · public preview data

Overview

What Jardiance covers.

Jardiance is a prescription medication containing empagliflozin, used to improve glycemic control in adults with type 2 diabetes and to reduce the risk of cardiovascular death. It belongs to the class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. The brand is marketed by Boehringer Ingelheim and Eli Lilly and Company.

  • Positioned as a mainstream brand.
  • Headquartered in Germany.

FAQ

Questions this page answers.

What does Jardiance do?

Jardiance is a food and beverage brand based in Germany, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.